SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,397 | -53.8% | 62,328 | 0.0% | 0.00% | – |
| Q2 2023 | $81,026 | -59.4% | 62,328 | -45.0% | 0.00% | – |
| Q1 2023 | $199,537 | -23.6% | 113,373 | +36.2% | 0.00% | – |
| Q4 2022 | $261,298 | -0.3% | 83,216 | +55.4% | 0.00% | – |
| Q3 2022 | $262,000 | -1.9% | 53,545 | -17.2% | 0.00% | – |
| Q2 2022 | $267,000 | -40.0% | 64,686 | -15.5% | 0.00% | – |
| Q1 2022 | $445,000 | -29.3% | 76,542 | -8.7% | 0.00% | – |
| Q4 2021 | $629,000 | -12.5% | 83,860 | +5.0% | 0.00% | – |
| Q3 2021 | $719,000 | -29.9% | 79,888 | -6.9% | 0.00% | – |
| Q2 2021 | $1,026,000 | -7.0% | 85,798 | -2.5% | 0.00% | -100.0% |
| Q1 2021 | $1,103,000 | -73.0% | 88,015 | -66.3% | 0.00% | -50.0% |
| Q4 2020 | $4,081,000 | +111.7% | 261,464 | +28.1% | 0.00% | +100.0% |
| Q3 2020 | $1,928,000 | -52.3% | 204,177 | -54.8% | 0.00% | -66.7% |
| Q2 2020 | $4,044,000 | +467.2% | 451,255 | +303.5% | 0.00% | +200.0% |
| Q1 2020 | $713,000 | -87.2% | 111,846 | -83.1% | 0.00% | -75.0% |
| Q4 2019 | $5,551,000 | -32.0% | 663,496 | -26.5% | 0.00% | -33.3% |
| Q3 2019 | $8,168,000 | -47.9% | 902,782 | -38.0% | 0.01% | -33.3% |
| Q2 2019 | $15,688,000 | +68.6% | 1,456,972 | +49.4% | 0.01% | +50.0% |
| Q1 2019 | $9,303,000 | +331.7% | 975,447 | +419.2% | 0.01% | +200.0% |
| Q4 2018 | $2,155,000 | -91.6% | 187,878 | -87.6% | 0.00% | -75.0% |
| Q3 2018 | $25,777,000 | +21.2% | 1,520,913 | +1.5% | 0.01% | +33.3% |
| Q2 2018 | $21,273,000 | +125.2% | 1,498,295 | +201.3% | 0.01% | +20.0% |
| Q1 2018 | $9,445,000 | +142.8% | 497,227 | +109.5% | 0.01% | +150.0% |
| Q4 2017 | $3,890,000 | -74.6% | 237,351 | -76.7% | 0.00% | -80.0% |
| Q3 2017 | $15,304,000 | +1128.3% | 1,020,336 | +619.6% | 0.01% | +900.0% |
| Q2 2017 | $1,246,000 | -38.5% | 141,796 | -63.6% | 0.00% | 0.0% |
| Q1 2017 | $2,027,000 | -0.5% | 389,981 | -41.6% | 0.00% | -50.0% |
| Q4 2016 | $2,037,000 | -44.8% | 668,176 | -16.1% | 0.00% | -33.3% |
| Q3 2016 | $3,687,000 | +27.2% | 796,825 | +59.1% | 0.00% | +50.0% |
| Q2 2016 | $2,899,000 | -24.7% | 500,899 | -21.3% | 0.00% | -33.3% |
| Q1 2016 | $3,849,000 | -11.5% | 636,708 | +33.6% | 0.00% | 0.0% |
| Q4 2015 | $4,347,000 | -31.1% | 476,441 | -57.4% | 0.00% | -40.0% |
| Q3 2015 | $6,310,000 | -16.2% | 1,119,395 | +64.8% | 0.01% | 0.0% |
| Q2 2015 | $7,529,000 | -17.4% | 679,262 | +16.8% | 0.01% | -16.7% |
| Q1 2015 | $9,115,000 | +469.0% | 581,561 | +450.4% | 0.01% | +500.0% |
| Q4 2014 | $1,602,000 | -38.5% | 105,666 | -56.3% | 0.00% | -50.0% |
| Q3 2014 | $2,605,000 | +23.8% | 241,849 | +75.2% | 0.00% | +100.0% |
| Q2 2014 | $2,104,000 | +6.4% | 138,025 | +26.2% | 0.00% | 0.0% |
| Q1 2014 | $1,977,000 | -36.5% | 109,403 | -51.2% | 0.00% | -50.0% |
| Q4 2013 | $3,114,000 | +5.7% | 224,358 | -20.1% | 0.00% | 0.0% |
| Q3 2013 | $2,945,000 | – | 280,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |